Cited by 111Alzheimer's disease research and treatmentsCellular transport and secretionUbiquitin and proteasome pathways

Ubiquitin Regulates GGA3-mediated Degradation of BACE1

Open access
Kang, Eugene L., Cameron, Andrew N., Piazza, Fabrizio, Walker, Kendall R., Tesco, Giuseppina·2010·Journal of Biological Chemistry

Abstract

BACE1 (beta-site amyloid precursor protein-cleaving enzyme 1) is a membrane-tethered member of the aspartyl proteases, essential for the production of beta-amyloid, a toxic peptide that accumulates in the brain of subjects affected by Alzheimer disease. The BACE1 C-terminal fragment contains a DXXLL motif that has been shown to bind the VHS (VPS27, Hrs, and STAM) domain of GGA1-3 (Golgi-localized gamma-ear-containing ARF-binding proteins). GGAs are trafficking molecules involved in the transport of proteins containing the DXXLL signal from the Golgi complex to endosomes. Moreover, GGAs bind ubiquitin and traffic synthetic and endosomal ubiquitinated cargoes to lysosomes. We have previously shown that depletion of GGA3 results in increased BACE1 levels and activity because of impaired lysosomal degradation. Here, we report that the accumulation of BACE1 is rescued by the ectopic expression of GGA3 in H4 neuroglioma cells depleted of GGA3. Accordingly, the overexpression of GGA3 reduces the levels of BACE1 and beta-amyloid. We then established that mutations in the GGA3 VPS27, Hrs, and STAM domain (N91A) or in BACE1 di-leucine motif (L499A/L500A), able to abrogate their binding, did not affect the ability of ectopically expressed GGA3 to rescue BACE1 accumulation in cells depleted of GGA3. Instead, we found that BACE1 is ubiquitinated at lysine 501 and is mainly monoubiquitinated and Lys-63-linked polyubiquitinated. Finally, a GGA3 mutant with reduced ability to bind ubiquitin (GGA3L276A) was unable to regulate BACE1 levels both in rescue and overexpression experiments. These findings indicate that levels of GGA3 tightly and inversely regulate BACE1 levels via interaction with ubiquitin sorting machinery.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m109.092742

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Ubiquitination at lysine 501 in the C-terminus of BACE1 is required for GGA3-mediated lysosomal targeting and degradation of BACE1.

    “Ubiquitination at lysine 501 in the C-terminus of BACE1 is required for GGA3-mediated lysosomal targeting and the degradation of BACE1 (29,30).”

    From BIN1 regulates BACE1 intracellular trafficking and amyloid-β production (2016) · cites this paper as [30]

    Figure 5 and its accompanying results (page not provided) show that Lys-501 is in BACE1’s C-terminus and that the K501R substitution greatly reduces BACE1 ubiquitination. The paper also links GGA3’s ubiquitin-binding ability to regulation of BACE1 levels and discusses lysosomal degradation, but it does not show that ubiquitination specifically at Lys-501 is required for GGA3-mediated lysosomal targeting or degradation. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Depletion of GGA3 resulted in reduced degradation of BACE1 in lysosomes and increased Ab production, similar to Bin1-depleted cells.

    “The depletion of GGA3, which recognizes ubiquitinated BACE1, resulted in the reduced degradation of BACE1 in the lysosomes and increased Ab production in a similar manner to that observed in Bin1-depleted cells (30,41).”
  • GGA3 regulates BACE1 trafficking to lysosomes and modulates BACE1 levels; depletion and overexpression of GGA3 inversely regulate BACE1 levels.

    “The Golgi-localized, γ-ear-containing clathrin adaptor ARF binding protein 3 (GGA3) regulates the trafficking of BACE1 to lysosomes, and modulates BACE1 levels through interactions with ubiquitin sorting machinery, where depletion and overexpression of GGA3 inversely regulates BACE1 levels [49, 50].”
  • Ubiquitination of BACE1 promotes its lysosomal degradation and is impaired in AD.

    “ubiquitination of BACE1 promotes its degradation in the lysosome and is impaired in AD (37,38).”

    From The β-Secretase BACE1 in Alzheimer’s Disease (2021) · cites this paper as [37]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Lu, Q., Hope, L. W., Brasch, M., Reinhard, C., and Cohen, S. N. (2003) Proc. Natl. Acad. Sci. U.S.A. 100, 7626 -7631
  2. Prag, G., Lee, S., Mattera, R., Arighi, C. N., Beach, B. M., Bonifacino, J. S., and Hurley, J. H. (2005) Proc. Natl. Acad. Sci. U.S.A. 102, 2334 -2339

Cited by

Sorted by citations

Authors
Kang, E. L., Cameron, A. N., Piazza, F., Walker, K. R., & Tesco, G.
Affiliations
Tufts University (US)
Corresponding author
Tesco, Giuseppina
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2010-07
Volume
285
Issue
31
Pages
24108-24119
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2032080482
Cited by
111
References
49
Citations by year
2026: 5 · 2025: 4 · 2024: 3 · 2023: 3 · 2022: 1 · 2021: 2 · 2020: 7 · 2019: 6 · 2018: 5 · 2017: 6 · 2016: 9 · 2015: 9 · 2014: 16 · 2013: 11 · 2012: 12
FWCI
7.37
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • BOA (University of Milano-Bicocca) (submittedVersion)
Funders
  • National Institutes of Health
  • National Institute on Aging (R01AG033016, R01AG025952)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
Keywords
BACE1, GGA3, ubiquitin, protein degradation, lysosomal degradation, dileucine motif, amyloid-beta, Alzheimer's disease, monoubiquitination
MeSH terms
Amino Acid Sequence, Animals, Gene Expression Regulation, Golgi Apparatus, Humans, Lysosomes, Molecular Sequence Data, Protein Binding, Endosomes, Signal Transduction, Amyloid beta-Peptides, Aspartic Acid Endopeptidases, Sequence Homology, Amino Acid, Ubiquitin, Adaptor Proteins, Vesicular Transport, Mice, Amyloid Precursor Protein Secretases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review